Pyruvate Dehydrogenase Kinase (PDK): An attractive target for anticancer therapy

by Madhok, Brijesh Madanmohan
Published 2012

Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer

by Bartlett John MS, Macaskill E Jane, Sabine Vicky S, Suleman Charlotte AB, Hanby Andrew M, Madhok Brijesh, Ingram Nicola, Coleman Louise J, Cookson Victoria J, Satheesha Sampoorna, Dixon J Michael, McElwaine Jim N, Hughes Thomas A
Published 2011-02-01